Form 4: Calix CFO Exercises Options, Sells Shares
Insider Transaction Report
Calix CFO Cory Sindelar exercised stock options and subsequently sold a portion of the acquired common stock under a pre-arranged trading plan.
Summary
- Calix CFO Cory Sindelar exercised 50,000 stock options at an exercise price of $5.05 per share.
- Concurrently, 50,000 shares of common stock were sold at a weighted average price of $65.2987 per share.
- These transactions were executed on November 6, 2025, under a Rule 10b5-1 trading plan.
- Following these transactions, beneficial ownership of common stock is 76,555 shares, and 175,000 stock options remain.
Sentiment
Score: 7
Explanation: The CFO exercised stock options at a low price and sold shares at a significantly higher market price, indicating a profitable transaction for the insider. The transaction was conducted under a Rule 10b5-1 plan, suggesting it was pre-scheduled and not a reaction to new information.
Positives
- CFO Cory Sindelar realized significant profit by exercising options at $5.05 and selling shares at a weighted average of $65.2987.
- The execution of these transactions under a Rule 10b5-1 plan indicates pre-planned activity, reducing concerns about opportunistic selling.
Negatives
- The sale of 50,000 shares by a key executive, even if pre-planned, could be interpreted by some investors as a reduction in insider exposure.
Stakeholder Impact
- Shareholders may view insider selling (even if pre-planned) with slight caution, but the profitability of the exercise could be seen as a positive signal on stock value.
Key Dates
| Date | Description |
|---|---|
| 10/01/2021 | 100% of the shares subject to the option were fully vested and exercisable. |
| 11/06/2025 | Transaction date for the exercise of stock options and the sale of common stock. |
| 11/10/2025 | Date the reporting person's signature was affixed to the filing. |
| 10/01/2027 | Expiration date of the stock options. |
Recommendation
holdThe filing details a pre-scheduled insider transaction (option exercise and sale) by the CFO. While the insider realized significant profits, the transaction was executed under a Rule 10b5-1 plan, which typically mitigates concerns about opportunistic selling. This filing alone does not provide sufficient new information to alter a fundamental investment thesis, thus a 'hold' recommendation is appropriate, pending further financial disclosures.
Keywords
Calix, CALX, Form 4, Insider Trading, Stock Option Exercise, Share Sale, CFO, Cory Sindelar, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.